|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Pediatric and Adolescent Osteosarcoma. Springer;
pp. 3–13. 2009, View Article : Google Scholar
|
|
2
|
Lindsey BA, Markel JE and Kleinerman ES:
Osteosarcoma Overview. Rheumatol Ther. 4:25–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harrison DJ, Geller DS, Gill JD, Lewis VO
and Gorlick R: Current and future therapeutic approaches for
osteosarcoma. Expert Rev Anticancer Ther. 18:39–50. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anderson ME: Update on survival in
osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang DQ, Fu P, Yao C, Zhu LS, Hou TY, Chen
JG, Lu Y, Liu D and Zhu LQ: Long non-coding RNAs, novel culprits,
or bodyguards in neurodegenerative diseases. Mol Ther Nucleic
Acids. 10:269–276. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Niu ZS, Niu XJ and Wang WH: Long
non-coding RNAs in hepatocellular carcinoma: Potential roles and
clinical implications. World J Gastroenterol. 23:5860–5874. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tehrani SS, Karimian A, Parsian H,
Majidinia M and Yousefi B: Multiple functions of long non-coding
RNAs in oxidative stress, DNA damage response and cancer
progression. J Cell Biochem. 119:223–236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iranpour M, Soudyab M, Geranpayeh L,
Mirfakhraie R, Azargashb E, Movafagh A and Ghafouri-Fard S:
Expression analysis of four long noncoding RNAs in breast cancer.
Tumour Biol. 37:2933–2940. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang X, Yan M, Chengjiang W, et al:
Analysis of LncRNAs and mRNAs expression profiles in ovarian
epithelial cancer cell lines by gene microarray. Chinese Journal of
Clinical Laboratory Science. 36:384–387,400. 2018.PubMed/NCBI
|
|
10
|
Xu C, Li Z, He T, Yuan B and Ding B: Long
noncoding RNA PTPRG-AS1 regulates growth of glioma cells by
sponging miR-185-5p. RSC Advances. 9:10870–10880. 2019. View Article : Google Scholar
|
|
11
|
Yi L, Ouyang L, Wang S, Li SS and Yang XM:
Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to
regulate radiosensitivity and metastasis of nasopharyngeal
carcinoma cells via PRC1. J Cell Physiol. 234:19088–19102. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cates JM: Comparison of the AJCC, MSTS,
and modified spanier systems for clinical and pathologic staging of
osteosarcoma. Am J Surg Pathol. 41:405–413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Laurini JA and Cooper K: Pathologic
staging of bone and soft tissue tumors: What is new in the eighth
edition of the American Joint Committee on Cancer Staging Manual?
AJSP. 23:149–156. 2018.
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen ZZ, Huang L, Wu YH, Zhai WJ, Zhu PP
and Gao YF: LncSox4 promotes the self-renewal of liver
tumour-initiating cells through Stat3-mediated Sox4 expression. Nat
Commun. 7:125982016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhuang J, Huang Y, Zheng W, Yang S, Zhu G,
Wang J, Lin X and Ye J: TMEM100 expression suppresses metastasis
and enhances sensitivity to chemotherapy in gastric cancer. Biol
Chem. 401:285–296. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mumprecht V and Detmar M:
Lymphangiogenesis and cancer metastasis. J Cell Mol Med.
13:1405–1416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol
Cancer. 14:482015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang J and Zhang W: New molecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun XH, Yang LB, Geng XL, Wang R and Zhang
ZC: Increased expression of lncRNA HULC indicates a poor prognosis
and promotes cell metastasis in osteosarcoma. Int J Clin Exp
Pathol. 8:2994–3000. 2015.PubMed/NCBI
|
|
21
|
Zhao H, Hou W, Tao J, Zhao Y, Wan G, Ma C
and Xu H: Upregulation of lncRNA HNF1A-AS1 promotes cell
proliferation and metastasis in osteosarcoma through activation of
the Wnt/β-catenin signaling pathway. Am J Transl Res. 8:3503–3512.
2016.PubMed/NCBI
|
|
22
|
Zhou S, Yu L, Xiong M and Dai G: LncRNA
SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by
upregulating Notch2 by sponging miR-195-5p. Biochem Biophys Res
Commun. 495:1822–1832. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y and Kong D: LncRNA GAS5 represses
osteosarcoma cells growth and metastasis via sponging MiR-203a.
Cell Physiol Biochem. 45:844–855. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu G, Wang L, Han H, Li Y, Lu S, Li T and
Cheng C: LncRNA ZFAS1 promotes growth and metastasis by regulating
BMI1 and ZEB2 in osteosarcoma. Am J Cancer Res. 7:1450–1462.
2017.PubMed/NCBI
|
|
25
|
Dong Y, Liang G, Yuan B, Yang C, Gao R and
Zhou X: MALAT1 promotes the proliferation and metastasis of
osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol.
36:1477–1486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Radisky DC: Epithelial-mesenchymal
transition. J Cell Sci. 118:4325–4326. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakajima S, Doi R, Toyoda E, Tsuji S, Wada
M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, et al: N-cadherin
expression and epithelial-mesenchymal transition in pancreatic
carcinoma. Clin Cancer Res. 10:4125–4133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nguyen PT, Kudo Y, Yoshida M, Kamata N,
Ogawa I and Takata T: N-cadherin expression is involved in
malignant behavior of head and neck cancer in relation to
epithelial-mesenchymal transition. Histol Histopathol. 26:147–156.
2011.PubMed/NCBI
|
|
36
|
Radisky ES and Radisky DC: Matrix
metalloproteinase-induced epithelial-mesenchymal transition in
breast cancer. J Mammary Gland Biol Neoplasia. 15:201–212. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Malemud CJ: Matrix metalloproteinases
(MMPs) in health and disease: An overview. Front Biosci.
11:1696–1701. 2006. View
Article : Google Scholar : PubMed/NCBI
|
